A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis by Nam, S Y et al.
A hypoxia-dependent upregulation of hypoxia-inducible factor-1
by nuclear factor-kB promotes gastric tumour growth and
angiogenesis
SY Nam
1,8,Y SK o
2,8, J Jung
2, J Yoon
2, YH Kim
3, YJ Choi
4, JW Park
4,5, MS Chang
6, WH Kim
6,7 and BL Lee*,2,5,7
1Radiation Health Research Institute, Korea Hydro & Nuclear Power Co., Ltd., Seoul 132-703, Korea;
2Department of Anatomy, Seoul National University
College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-799, Korea;
3Inha University College of Medicine, Incheon 402-751, Korea;
4Department
of Pharmacology, Seoul National University College of Medicine, Seoul 110-799, Korea;
5Ischemic/Hypoxic Disease Institute Medical Research Center,
Seoul National University College of Medicine, Seoul 110-799, Korea;
6Department of Pathology, Seoul National University College of Medicine, Seoul
110-799, Korea;
7Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea
BACKGROUND: The underlying mechanisms involved in the activation of hypoxia-inducible factor-1 (HIF-1) in gastric cancer remain
unclear. As nuclear factor-kB (NF-kB) as well as HIF-1 have been implicated in angiogenesis of various cancers, we investigated their
relationship in gastric cancer.
METHODS: Nuclear expressions of HIF-1a and NF-kB/RelA were assessed in 251 human gastric carcinoma specimens by
immunohistochemical tissue array analysis. Stable human gastric cancer cells, infected with a retroviral vector containing super-
suppressive mutant form of IkBa (IkBaM), were used for animal studies as well as cell culture experiments. Xenografted tumours
were measured and IkBaM effects on angiogenesis and HIF-1a activation were assessed by immunohistochemistry, western blotting,
luciferase reporter assay, and semiquantitative reverse transcription–polymerase chain reaction. In addition, NF-kB effects on the
HIF-1a degradation and synthesis were examined.
RESULTS: Hypoxia-inducible factor-1a activation positively correlated with RelA activation in clinical gastric cancer samples (Po0.001).
The IkBaM overexpression suppressed tumour growth, microvessel density, and HIF-1a activation in xenografted tumours. Cell
culture experiments showed that hypoxia-induced HIF-1a expression was reduced by NF-kB inhibition under hypoxic conditions at
the translational level.
CONCLUSION: The hypoxia-dependent activation of the NF-kB/HIF-1a/VEGF pathway contributes, at least in part, to gastric cancer
promotion via enhancement of angiogenesis.
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Hypoxia commonly develops within solid tumours and stimulates
the expression of several genes responsible for tumour cell
survival, proliferation, and angiogenesis (Royds et al, 1998;
Giatromanolaki and Harris, 2001). As hypoxia induces the
development of a clinically aggressive tumour phenotype as well
as resistance to chemotherapy and radiation (Royds et al, 1998;
Ho ¨ckel and Vaupel, 2001), many elements of the hypoxia-response
pathway are good candidates for therapeutic targets. However, the
mechanism that relates hypoxia to these tumour characteristics
has remained unclear.
Hypoxia-inducible factor-1 (HIF-1) is a key transcription factor
that regulates blood vessel formation by affecting the expression of
vascular endothelial growth factor (VEGF) (Forsythe et al, 1996;
Hong et al, 2004). It has a key role in cellular responses to hypoxia
in both normal and malignant cells (Iyer et al, 1998; Semenza,
2000). As HIF-1 is a heterodimeric transcription factor composed
of oxygen-dependent HIF-1a and constitutively expressed HIF-1b
subunits, HIF-1 transcriptional activity is largely determined by
regulated expression of the HIF-1a subunit (Semenza, 2001).
Although HIF-1a is stabilised under hypoxic conditions because of
its oxygen-dependent degradation domain that binds with the von-
Hippel-Lindau protein (pVHL)-containing complex, non-hypoxic
activation of HIF-1a by cytokines, oncogenes, and reactive oxygen
species has also been reported (Dery et al, 2005). However, the
detailed molecular mechanism underlying HIF-1 activation could
be different according to cell type (Li et al, 2005).
Nuclear factor-kB (NF-kB) is a critical transcription factor in
various cancers that regulates genes associated with a variety of
cellular functions, such as cell survival, proliferation, angiogenesis,
and cancer metastasis (Guttridge et al, 1999; Baldwin, 2001a,b;
Karashima et al, 2003; Meir et al, 2007). Nuclear factor-kBi s
normally sequestered in the cytoplasm of nonstimulated cells by a
family of inhibitory proteins, IkBs, which bind to NF-kB and mask
the nuclear localisation signal domain of NF-kB. Once cells are
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sexposed to extracellular stimuli, IkBs become phosphorylated,
ubiquitinated, and degraded by the proteasomes, leading to NF-kB
activation (Gilmore, 1999).
Both HIF-1 and NF-kB are involved in cancer progression
(Rayet and Ge ´linas, 1999; Hare et al, 2008) and have been
implicated in the tumour responses to hypoxia (Royds et al, 1998;
Karashima et al, 2003; Yokoi and Fidler, 2004). Previously,
a positive correlation between HIF-1a and NF-kB was shown in
surgical colorectal cancer specimens (Kwon et al, 2010). In
addition, in vivo animal and in vitro cell culture studies showed
that HIF-1a activation was induced by NF-kB in various cancer
cells, including lung cancer cells, colon cancer cells, and
osteosarcoma cells (Jung et al, 2003; Van Uden et al, 2008).
However, these experiments were done mainly under normoxic
conditions and little is known about this relationship in cancer
cells under hypoxic conditions.
In gastric cancer, both HIF-1a (Zhong et al, 1999; Urano et al,
2006) and NF-kB (Lee et al, 2005) have been reported to be
overexpressed in surgical samples. Although HIF-1a was shown to
increase angiogenesis and tumour growth of gastric cancer
(Stoeltzing et al, 2004), the regulatory mechanism of HIF-1a
activation in gastric cancer remains unclear. The present study
investigated the correlation between HIF-1a and NF-kB RelA
in 251 surgically excised human gastric carcinoma tissues. In
addition, we performed cell culture and animal studies after
establishment of a stable gastric cancer cell line overexpressing
supersuppressive mutant form of IkBa (IkBaM).
MATERIALS AND METHODS
Patients and tissue array methods
A total of 251 surgically resected human gastric cancer
specimens were obtained from the Department of Pathology,
Seoul National University College of Medicine from 1 January to
30 June, 1995, and six paraffin array blocks were prepared by
Superbiochips Laboratories (Seoul, Korea), as previously described
(Lee et al, 2003). Briefly, core tissue biopsies (2mm in diameter)
were taken from individual paraffin-embedded gastric tumours
(donor blocks) and arranged in a new recipient paraffin block
(tissue array block) using a trephine apparatus. As we have
reported previously (Lee et al, 2001), the staining results of the
different intratumoural areas of gastric carcinomas in these tissue
array blocks showed an excellent agreement. A core was chosen
from each case for the analysis. We defined an adequate case as a
tumour occupying 410% of the core area. This protocol was
reviewed and approved by the institutional review board of the
Seoul National University (approval no. C-0603-162-170).
Cell culture
A human gastric cancer cell line SNU-668 was obtained from
the Korean Cell Line Bank (Seoul, Korea), cultured in RPMI-1640
medium (Life Technologies, Grand Island, NY, USA) containing
10% fetal bovine serum (Life Technologies), and maintained in
a3 71C humidified incubator containing 95% air and 5% CO2.
Infection with retroviral vectors expressing IjBa
supersuppressor
The control retroviral vector MFG.EGFP.IRES.puro has been
previously described (Oh et al, 2001). MFG.EGFP.IRES.puro
and the retroviral vector MFG.IkBaM.IRES.puro, which encodes
an IkBaM, were generated and infected into three gastric
cancer cell lines, as described previously (Lee et al, 2005;
Cho et al, 2008).
In vivo tumourigenesis assay
Eight-week-old male athymic nude mice (BALB/cSlc-nu) were
purchased from SLC Inc. (Hamamatsu, Shizuoka, Japan). All
animal procedures were performed in accord with the procedures
described in Workman et al (2010). Tumours were established
by injecting 1 10
7 gastric cancer cells (SNU-668
Vector or
SNU-668
IkBaM cells) in 100ml of Matrigel (provided by Professor
Hynda K Kleinman, George Washington University, Washington
DC, USA) subcutaneously (s.c.) into both flanks of each of ten
mice. Tumours were measured on alternate days using a caliper,
and the tumour volumes were calculated using the following
formula: (length width height) (p/6). After killing, tumour
xenografts were removed and prepared for immunohistochemistry
or immunoblotting.
Tumour histology and immunohistochemistry
Tissue specimens were fixed with 10% neutral-buffered formalin,
and 4mm paraffin sections were then prepared. One section was
stained with haematoxylin and eosin (H&E) for histological
assessment, and the other sections were immunostained using
a streptavidin peroxidase procedure after microwave antigen
retrieval. The primary antibodies were anti-NF-kB p65 (1:50;
Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-proliferating
cell nuclear antigen (PCNA) (1:100; DAKO, Carpinteria, CA,
USA), anti-cleaved caspase-3 (1:100; Cell Signaling Technology,
Beverly, MA, USA), anti-CD31 (1:100; Santa Cruz Biotechnology),
and anti-HIF-1a (1:50, provided by Dr Jong-Wan Park in Seoul
National University, Seoul). Specimens were incubated with the
biotinylated secondary antibody against the corresponding
primary antibody and then with avidin–biotin–peroxidase com-
plex (Vectastain Elite ABC kit, Vector Laboratories, Burlingame,
CA, USA). Visualisation was performed using diaminobenzidine
(DAB). All immunostained sections were then lightly counter-
stained with Mayer’s haematoxylin. Throughout the above
analysis, negative controls were prepared by omitting the primary
antibody. For PCNA staining, we evaluated 500 cells and counted
the cells with nuclear staining for each specimen. The proliferation
index was defined as follows: proliferation index (%)¼100 
PCNA-positive cells/total cells.
Quantification of microvessel density in xenograft
tumours
Microvessel densities (MVDs) were determined by light micro-
scopy/optical image analysis after immunostaining xenograft
tumour sections with anti-CD31 antibody as described previously
(Stoeltzing et al, 2004). The three most highly vascularised areas in
areas of tumours near the tumour–normal tissue interface were
selected. Photographs of CD31-immunopositive vessels in tumour
sections were taken under a light microscope, and the cross-
sectional areas of CD31-immunopositive structures (i.e., vessel
areas) were quantified by capturing images, converting them to
greyscale, and analyzing CD31-stained areas using NIH Image
Analysis software (version 1.62; National Institute of Health,
Bethesda, MD, USA) after setting one consistent intensity thresh-
old for all slides. Then, CD31-positive areas were expressed as
pixels squared per high-power field and were measured for all
tumours.
Transient transfection and luciferase reporter assay
The NF-kB-luciferase reporter plasmid (pNF-kB-luciferase)
(Stratagene, La Jolla, CA, USA) contains a 5  NF-kB response
element fused to luciferase. To determine whether NF-kB activity
is controlled by hypoxia, SNU-668 cells were transiently
co-transfected with 0.4mg of pNF-kB-luciferase and 0.4mgo f
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sb-galactosidase vector, an internal control, using LipofectAMINE
Plus (Life Technologies). At 24h after transfection, SNU-668 cells
were incubated under either normoxic or hypoxic conditions.
Luciferase activity was measured on an AutoLumat LB 9505c
luminometer (Berthold Analytical Instruments, Nashua, Germany)
and normalised by b-galactosidase activity. Luciferase activities are
presented as relative values vs the normoxic level of the empty
vector control.
Preparation of nuclear and cytoplasmic extracts
Cells were lysed in 100ml buffer A (10mMl
 1 Tris (pH 8.0),
60mMl
 1 NaCl, 1mMl
 1 EDTA, 1mMl
 1 DTT, 0.1% NP-40, and
1m Ml
 1 phenylmethylsulphonyl fluoride), incubated on ice for
5min, and centrifuged (pulsing for 5s at 41C), and the cytoplasmic
extracts obtained (the supernatant) were transferred to fresh tubes.
Glycerol was then added to 20%, and the extracts were stored
at  801C until required. The pelleted nuclei were immediately
washed in 1ml buffer A without NP-40, spun as described
above, and resuspended in 50ml buffer B (200mMl
 1 HEPES
(pH 7.9), 0.75mMl
 1 spermidine, 0.15mMl
 1 spermine,
0.2mMl
 1 EDTA, 2mMl
 1 EGTA, 2mMl
 1 DTT, 20% glycerol,
1m Ml
 1 phenylmethylsulphonyl fluoride, and 0.4 Ml
 1 NaCl).
They were then extracted on ice for 10min with occasional
vortexing and centrifuged, and the supernatant was collected as
nuclear extract and stored at  801C until required.
Lentivirus-mediated short hairpin RNA (shRNA) silencing
of HIF-1a
Hypoxia-inducible factor-1a shRNA lentiviral particles and control
shRNA lentiviral particles were purchased from Santa Cruz
Biotechnology. The HIF-1a shRNA lentiviral particles is a pool
of concentrated, transduction-ready viral particles containing
three target-specific constructs that encode 19–25nt (plus hairpin)
shRNA designed to knock down gene expression. Construct in the
control shRNA lentiviral particle encodes a scrambled shRNA
sequence. The viral infection was performed by incubating
SNU-668, SNU-216, and SNU-484 gastric cancer cells in the
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Figure 1 Representative immunohistochemical features of HIF-1a and NF-kB in human gastric cancer specimens. Positive (A and B) vs negative
(C and D) examples of gastric cancer for HIF-1a (A and C) and NF-kB( B and D). (E) A negative control of gastric cancer specimen treated without
primary antibodies. Scale bars¼50mm.
Table 1 Correlation between the nuclear expressions of HIF-1a and
NF-kB in human gastric carcinomas
HIF-1a
(nuclear)
HIF-1a (negative and
cytoplasm)
n (%) n (%) P-value
NF-kB
Nuclear 24 (52) 22 (48) o0.001
a
Negative and cytoplasm 45 (22) 160 (78)
Abbreviations: HIF-1¼hypoxia-inducible factor-1; NF-kB¼nuclear factor-kB.
aConsidered to be statistically significant.
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sculture medium containing lentiviral particles for 12h in the
presence of 5mgml
 1 Polybrene (Santa Cruz Biotechnology).
Pooled puromycin (2mgml
 1)-resistant cells were harvested and
stored for further analysis.
Protein isolation and western blotting
Cells were lysed with 1  Laemmli lysis buffer (2.4 M glycerol,
0.14 M Tris (pH 6.8), 0.21 M SDS, and 0.3mM bromophenol blue)
and then boiled for 10min. Protein contents were measured using
BCA Protein Assay Reagent (Pierce, Rockford, IL, USA). Samples
were diluted with 1  lysis buffer containing 1.28 M b-mercap-
toethanol, and equal amounts of protein were loaded onto 8–12%
SDS–polyacrylamide gels. Proteins were electrophoretically
transferred to PVDF or nitrocellulose membranes, and membranes
were then blocked with 5% nonfat dry milk in PBS/Tween-20
(0.1%, vol/vol) at 41C overnight. They were then incubated with
a primary antibody against IkBa (1:1000; Cell Signaling
Technology), NF-kB/p65 (1:1000; Santa Cruz Biotechnology),
HIF-1a (1:250; BD transduction Laboratories, San Diego, CA,
USA), VEGF (1:1000; Santa Cruz Biotechnology), b-actin (1:5000;
Sigma, St Louis, MO, USA), or transcription factor IIB (TFIIB)
(1:250; BD Transduction Laboratories) for 3h. They were then
incubated with a corresponding secondary antibody, either
horseradish peroxidase-conjugated anti-rabbit IgG (1:2000;
Zymed, San Francisco, CA, USA) or anti-mouse IgG (1:2500;
Santa Cruz Biotechnology) for 2h, and enhanced chemilumines-
cence (ECL) (Amersham Biosciences, Arlington Heights, IL, USA)
was used for the visualisation of the immunoreactive proteins.
Equal loading of the protein was confirmed by b-actin (for
cytoplasmic proteins) and TFIIB (for nuclear proteins).
Semiquantitative reverse transcription–polymerase chain
reaction (SQ RT–PCR)
To quantify mRNA levels, we used a highly sensitive, SQ RT–PCR
method, as previously described (Chun et al, 2001). Total RNAs
were isolated using TRIZOL reagent purchased from Invitrogen
(Carlsbad, CA, USA), and 1mg of RNAs were reverse-transcribed at
481C for 30min. Complementary DNAs were amplified over 18
PCR cycles (941C for 30s, 521C for 30s, and 701C for 30s) in a
reaction mixture containing 5mCi (a-
32P)dCTP (NEN, Boston, MA,
USA). The resulting PCR fragments (5ml) were electrophoresed on
a 2% agarose gel at 100V in 1  TAE, and the gels were dried and
autoradiographed. Primer sequences were 50-CCCCAGATTCAGGA
TCAGACA-30 and 50-CCATCATGTTCCATTTTTCGC-30 for HIF-1a,
50-GGTGAAGTTCATGGATGTCT-30 and 50-TCTGCATTCACATTT
GTTGT-30 for VEGF, and 50-ACACCTTCTACAATGAGCTG-30 and
50-CATGATGGAGTTGAAGGTAG-30 for b-actin.
Assessment of cell viability
SNU-668, SNU-484, and SNU-216 gastric cancer cells (2.5 10
4 cells)
were seeded into each well of 24-well plates and were allowed to grow
under hypoxic conditions for 0–72h. Cell numbers were then
measured indirectly using the method reported by Kim et al
(Hur et al, 2003). Briefly, cells were stained with 0.2% crystal violet
aqueous solution in 20% methanol for 10min, dissolved in 10% SDS,
transferred into 96-well plates, and the absorbance was measured at
570nm using an ELISA reader (Bio-Rad, Hercules, CA, USA).
Statistical analysis
For tissue array analysis, statistical analyses were conducted using
SPSS Version 11.0 statistical software program (SPSS, Chicago, IL,
USA), and the w
2-test was used to determine the correlation
between the nuclear expressions of NF-kB and HIF-1a. For the
animal and cell experiments, data were analyzed using SAS
software (version 8.1; SAS Institute Inc., Cary, NC, USA), and the
two-tailed Student’s t-test was used to determine the significances
of the results. The P-values of o0.05 were considered significant
for all statistical analyses.
RESULTS
HIF-1a activation in relation to NF-jB activation in clinical
gastric cancer samples
To confirm the correlation between HIF-1a and NF-kB in human
gastric cancer tissues, we performed immunohistochemistry on
tissue array slides containing 251 human gastric cancer specimens.
Figure 1 shows that both HIF-1a (Figure 1A) and NF-kB
(Figure 1B) are expressed in both the nucleus and the cytoplasm
of tumour cells. Cells showing distinct nuclear staining, regardless
of the presence of cytoplasmic staining, were considered to
express activated HIF-1a or NF-kB. Immunostaining results were
considered to be positive when X5% (for HIF-1a) and X10%
(for NF-kB) of tumour cell nuclei were stained (Figure 1A and B,
respectively). Positive immunoreactivity for nuclear HIF-1a was
found in 69 of 251 (27%) gastric cancer specimens. In addition,
nuclear NF-kB was found in 46 of 251 (18%) of gastric cancer
specimens. Data concerning the correlation between the acti-
vations of HIF-1a and NF-kB are summarised in Table 1. Nuclear
HIF-1a expression was found to be significantly and positively
correlated with nuclear NF-kB expression (Po0.001).
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Figure 2 Effect of NF-kB inhibition on tumour growth in a xenograft
tumour model. Each mouse was ectopically implanted with gastric cancer
cells mixed in Matrigel on both flanks. (A) SNU-668 cells were transduced
with the MEG.IkBaM.IRES.puro (IkBaM) retroviral vector or MEG.EGFP.IR-
ES.puro as a control empty vector. Immunoblotting for IkBa or NF-kB
protein was performed using an anti-IkBa- or an anti-NF-kB p65 antibody,
respectively. b-Actin or transcription factor IIB (TFIIB) was used as a control
for cytoplasmic (Cyt) or nuclear (Nuc) protein, respectively. Immuno-
reactive proteins were visualised by enhanced chemiluminescence. (B)A
representative nude mouse bearing xenograft tumours derived from
SNU-668
IkBaM cells (right flank) and SNU-668
Vector cells (left flank).
Photographs were taken 54 days after s.c. injection. (C)T u m o u rs i z ew a s
measured over time. Values represent the means±s.d. (n¼7) of tumour size
and were analyzed using the Student’s t-test. *Po0.05 vs SNU-668
Vector.
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Figure 3 Representative immunohistochemical findings of the effect of IkBaM overexpression in differently sized xenograft tumours derived from
SNU-668
Vector cells (left lanes) or SNU-668
IkBaM cells (right lanes). Tumour sections were stained with H&E (A and B), anti-NF-kB p65 (C and D),
anti-PCNA (E and F), anti-cleaved caspase-3 (G and H), anti-CD31 (I and J), or anti-HIF-1a (K and L). All sections were lightly counterstained with
haematoxylin. Scale bars¼50mm.
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sEffect of NF-jB inhibition on tumour growth and MVD in
the nude mouse xenograft model
In order to confirm the correlation between HIF-1a and NF-kB
observed in the clinical gastric cancer samples, we produced
stable SNU-668 cell lines overexpressing either empty vector
(SNU-668
Vector)o rI kBaM (SNU-668
IkBaM). Western blotting
showed that IkBaM overexpression inhibited the nuclear trans-
location of NF-kB p65 in SNU-668 cells (Figure 2A).
We then established gastric carcinoma xenografts derived from
these cells and examined the effects of NF-kB p65 inhibition on
tumour growth. We found that 7 out of 10 mice showed tumour
formation (Figure 2B). On the final day of measurement (day 54),
SNU-668
IkBaM tumours (mean¼170.0mm
3) were significantly
smaller than SNU-668
Vector tumours (mean¼1490.6mm
3)
(P¼0.035; Figure 2C). These results indicated that NF-kB inhibi-
tion suppresses the gastric tumour growth.
To investigate the mechanism by which NF-kB promotes gastric
tumour growth, we performed immunohistochemistry on xeno-
graft tissue sections. First, we identified that nuclear NF-kB
p65 expression was less frequent in SNU-668
IkBaM tumours than in
SNU-668
Vector tumours (Figure 3C and D), indicating that NF-kB
activation was inhibited by IkBaM overexpression in tumours.
Next, the protein expressions of PCNA, a proliferation-related
marker, and cleaved caspase-3, an apoptosis-related marker,
were analyzed. The immunoreactivity of PCNA was found
less frequently in the nuclei of SNU-668
IkBaM tumour cells than
in those of SNU-668
Vector tumour cells (P¼0.012; Figures 3E and
F and 4A). In addition, the immunoreactivity of cleaved caspase-3
was enhanced in SNU-668
IkBaM tumour cells compared with in
SNU-668
Vector tumour cells (Figure 3G and H). Thus, the NF-kB
activity in the gastric cancer xenograft appears to be correlated
positively with cell proliferation, and negatively with apoptosis.
We then examined whether NF-kB activity was associated
with tumour angiogenesis. Immunohistochemical staining of an
endothelial cell marker CD31 was performed on tissue sections
of xenografted tumours (Figure 3I and J). Optical image analyses
showed that the CD31-positive vessel area was noticeably smaller
in SNU-668
IkBaM tumours (mean¼2.6 10
6pixels
2) than in
SNU-668
Vector tumours (mean¼10.4 10
6pixels
2)( Po0.001;
Figure 4C). Thus, the NF-kB p65 activity is likely to be positively
correlated with angiogenesis in gastric tumours.
Effect of NF-jB inhibition on HIF-1a and VEGF expression
Hypoxia-inducible factor-1a was previously found to increase
angiogenesis and tumour growth in gastric cancer (Stoeltzing et al,
2004). As the present study showed that IkBaM overexpression
suppressed MVD in xenografted tumours derived from SNU-668
cells, we assessed whether HIF-1a mediates the effect of NF-kB
activation in gastric cancer. Immunohistochemistry showed that
the frequency of HIF-1a-positive cells was significantly lower in
SNU-668
IkBaM tumours (mean¼16.6%) than in SNU-668
Vector
tumours (mean¼26.2%; P¼0.001; Figures 3K, L and 4B). Thus,
these results indicate that HIF-1a is a downstream molecule
of NF-kB.
Furthermore, to exclude the possibility that this difference in
HIF-1a immunoreactivity is correlated with the size of xeno-
graft tumours rather than NF-kB activity, we compared HIF-1a
expression in three sets of similarly sized xenograft tumours: the
sizes of SNU-668
IkBaM tumours were 251.2, 255.2, and 255.8mm
3,
and the sizes of corresponding vector control tumours were 255.4,
256.3, and 259.5mm
3. Western blot analysis showed that IkBaM
overexpression decreased the expressions of HIF-1a and VEGF in
similar sized tumours (Figure 4D).
As hypoxia is an important environment for tumour growth and
progression, we performed in vitro cell culture experiments and
investigated the correlation between hypoxia and the NF-kB
activation in gastric cancer cells. Luciferase reporter assay showed
that hypoxia induced NF-kB activation in SNU-668
Vector cells after
2h of hypoxia (P¼0.009 vs normoxic control), and that basal
NF-kB activity was essential for hypoxia-induced NF-kB activation
in gastric cancer cells (Figure 5A). In addition, IkBaM over-
expression reduced HIF-1a protein expression under hypoxic
conditions (Figure 5B, top). However, SQ RT–PCR showed that
IkBaM overexpression did not alter the expression of HIF-1a
mRNA, although it decreased the expression of hypoxia-induced
VEGF mRNA in SNU-668
IkBaM cells (Figure 5B, bottom). Consis-
tent results were shown in other gastric cell lines SNU-484
(Figure 5C) and SNU-216 (Figure 5D).
Effects of IjBaM overexpression on the degradation and
de novo synthesis of HIF-1a protein
To obtain a better understanding of the mechanism involved in
NF-kB-induced HIF-1a activation in gastric cancer cells, we
investigated whether IkBaM stimulates HIF-1a degradation or
inhibits its synthesis. Using three gastric cancer cell lines, we first
analyzed the effect of NF-kB on the oxygen-dependent degradation
of HIF-1a protein. Hypoxia-inducible factor-1a was first stabilised
by exposure to hypoxia, and then destabilised by re-oxygenation.
We found that IkBaM overexpression did not affect the oxygen-
dependent degradation rate of HIF-1a protein (Figure 5E). Next,
we checked whether IkBaM overexpression inhibits the synthesis
of HIF-1a protein. Cells were pretreated with cycloheximide to
remove the remaining HIF-1a, and further degradation of HIF-1a
protein was blocked using a proteasome inhibitor MG132. We then
examined the time course of HIF-1a accumulation. Figure 5F
shows that HIF-1a protein was substantially synthesised after 4h
and that the de novo synthesis of HIF-1a was impaired by IkBaM
overexpression. These results indicate that IkBaM overexpression
inhibits synthesis, not stabilisation, of HIF-1a protein. Thus, the
hypoxic activation of NF-kB seems to contribute to the expression
of HIF-1a protein at the translational level.
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Figure 4 Effects of IkBaM overexpression on gastric cancer xenografts.
(A–C) The frequencies of immunopositive cells for PCNA (A) or HIF-1a
(B) and the areas of blood vessels immunostained for CD31 (C)i n
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viability in vitro under hypoxic conditions
To investigate the role of HIF-1a in gastric tumour growth derived
from SNU gastric cancer cells, we blocked the HIF-1a pathway in
three gastric cancer cell lines using shRNA expression. Our results
showed that shRNA-mediated downregulation of HIF-1a expres-
sion reduced the cell viability of SNU-668, SNU-484, and SNU-216
gastric cancer cells in vitro under hypoxic conditions (Figure 6).
These data are consistent with a previous in vivo findings reported
by Stoeltzing et al (2004), who showed that xenografted
tumours derived from human gastric cancer TMK-1 cells over-
expressing dominant-negative-HIF-1a had smaller volumes than
those derived from vector control cells.
DISCUSSION
Gastric cancer is one of the most common malignancies worldwide
and the leading cause of cancer-related motility in Asian countries
(Parkin et al, 1993). Although angiogenesis is an important aspect
of tumour growth and progression and is considered the most
important predictor of overall survival in gastric cancer (Gong
et al, 2005), little is known about the molecular events critical to
the gastric cancer angiogenesis.
Previously, it was found that HIF-1a activation was signi-
ficantly correlated with VEGF protein expression, and this over-
expression was a prognostic factor in patients with gastric cancer
(Mizokami et al, 2006; Urano et al, 2006). Although it was
shown that HIF-1a inhibition reduced angiogenesis and tumour
growth in xenografted gastric tumours (Stoeltzing et al, 2004), it
has become evident that the mechanism underlying the activation
of HIF-1 in various cancer cells depends on cancer type (Li et al,
2005). In the present study, NF-kB inhibition suppressed
angiogenesis, as was manifested by decreased MVD, and tumour
growth of gastric cancer xenografts. Consistently, HIF-1a shRNA
expression decreased the cell growth of gastric cancer cell lines.
In addition, immunohistochemical tissue array analysis showed
that HIF-1a was constitutively expressed in 27% of the 251 surgical
samples of gastric carcinomas, and that this was positively
correlated with NF-kB activation (Po0.001). Thus, we investigated
whether HIF-1a mediates the role of NF-kB in gastric cancer
angiogenesis.
HIF-1
VEGF
-actin
HIF-1
-actin
48 24 8 4 0 Hypoxia
–+ –+ –+–+ –+ IBM
W
B
R
T
–
P
C
R
SNU-668
SNU-668
SNU-484
SNU-216
ReO2 (min)
Vector
025 1 0
IBM
02 5 1 0
HIF-1
HIF-1
HIF-1
MG132 (h)
-actin
-actin
-actin
IBM
02 8
Vector
02 8
SNU-216
W
B
R
T
–
P
C
R
HIF-1
HIF-1
VEGF
h 0 24
IBM
IBM
Hypoxia
– –
h 0 Hypoxia
SNU-484
– –
W
B
R
T
–
P
C
R
HIF-1
-actin
-actin -actin
-actin
HIF-1
VEGF
h 0 24
0 Hypoxia
IBM
IBM
Hypoxia
+
h
SNU-668
p
N
F
-

B
-
L
u
c
 
a
c
t
i
v
i
t
y
Hours under hypoxia
0
0
2
4
6
8
Vector
IBM
0.009
0.009
0.014
6 4 2
h
8
+
– –+ +
8
+ +
– –+ +
4 4
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cells infected with a retrovirus overexpressing IkBaM, which could
prove to be a powerful tool to obtain further insight into the role of
NF-kB in the regulation of HIF-1 activity. We found that IkBaM
overexpression decreased HIF-1a protein expression as well as
MVD in xenograft tumours. In addition, IkBaM overexpression
decreased VEGF mRNA expression in cell culture experiments.
Thus, these results suggest that HIF-1a is a downstream molecule
of NF-kB in the angiogenesis pathway in gastric cancer.
Hypoxia-inducible factor-1 activation was shown to be induced
by NF-kB in lung cancer cells and colon cancer cells under
normoxic conditions (Jung et al, 2003; Van Uden et al, 2008). In
contrast, HIF-1 activation by NF-kB was hypoxia dependent in
smooth muscle cells and embryonic kidney cells (Belaiba et al,
2007; Van Uden et al, 2008). In the present study, through a cell
culture system, we found that hypoxia was involved in the NF-kB
effect on the expressions of HIF-1a protein and VEGF mRNA in
gastric cancer cells. Thus, the NF-kB/HIF-1/VEGF pathway in
gastric cancer cells might be activated under hypoxic conditions.
In the present study, cell culture experiments showed that
NF-kB inhibition suppressed hypoxia-induced HIF-1a protein
expression, but not HIF-1a mRNA expression. Furthermore, we
found that IkBaM overexpression inhibited synthesis, not degrada-
tion, of HIF-1a protein. Thus, the hypoxic activation of NF-kB
seems to contribute to the accumulation of HIF-1a protein at the
translational level, but not at the transcriptional or post-transla-
tional level. These results are not in accord with earlier findings
shown in normal cells such as smooth muscle cells (Belaiba et al,
2007) and embryonic kidney cells (Van Uden et al, 2008), which
suggested that NF-kB targets and transactivates the HIF-1a gene.
This discrepancy may come from the different cell types (cancer cell
vs non-cancer cells), as the mechanism underlying the activation of
HIF-1a is specifically tailored according to cell type (Li et al, 2005).
In conclusion, the results obtained from human gastric cancer
specimens, gastric tumour xenografts, and cell culture experiments
indicate that HIF-1a mediates NF-kB-induced angiogenesis by
increasing VEGF expression and MVD, and that this occurs under
hypoxic conditions. Thus, HIF-1a and NF-kB may be candidate
molecular targets for gastric cancer therapy, and in particular,
blocking the NF-kB/HIF-1a pathway with appropriate inhibitors
might be useful therapeutically for treating gastric carcinoma.
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